Cue Biopharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Cue Biopharma, Inc. (CUE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.32 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.31M shares, a 2590.76% increase year-over-year.
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 6.96K shares, a 99.63% decline year-over-year.
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 3.06M shares, a 77.65% increase year-over-year.
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 4.99M shares, a 13.92% increase from fiscal 2024.
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 4.38M shares, a 69.12% increase from fiscal 2023.
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.59M shares, a 212.84% increase from fiscal 2022.
- Cue Biopharma, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 828.50K shares, a 33.77% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.31M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 1.32M shares 10-Q · filed 2026-08-14 | 1.32M shares derived: sum of 3 quarters · filed 2026-08-14 | 4.38M shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 6.96K shares 10-Q · filed 2026-05-14 | 6.96K shares derived: sum of 2 quarters · filed 2026-05-14 | 3.06M shares derived: sum of 3 quarters · filed 2026-05-14 | 3.11M shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 3.06M shares derived: sum of 2 quarters · filed 2026-03-16 | 3.10M shares derived: sum of 3 quarters · filed 2026-03-16 | 4.99M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 3.06M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 3.10M shares derived: sum of 2 quarters · filed 2025-11-12 | 4.99M shares 10-Q · filed 2025-11-12 | 5.19M shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-06-30 | 48.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 1.94M shares 10-Q · filed 2025-08-12 | 2.14M shares derived: sum of 3 quarters · filed 2026-03-16 | 3.86M shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-03-31 | 1.89M shares 10-Q · filed 2025-05-12 | 2.09M shares derived: sum of 2 quarters · filed 2026-03-16 | 3.81M shares derived: sum of 3 quarters · filed 2026-03-16 | 4.40M shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-12-31 | 200.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 1.92M shares derived: sum of 2 quarters · filed 2026-03-16 | 2.51M shares derived: sum of 3 quarters · filed 2026-03-16 | 4.38M shares 10-K · filed 2026-03-16 |
| 2024-09-30 | 1.72M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 2.31M shares derived: sum of 2 quarters · filed 2024-11-14 | 4.18M shares 10-Q · filed 2024-11-14 | 4.20M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | 593.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 2.46M shares 10-Q · filed 2024-08-14 | 2.48M shares derived: sum of 3 quarters · filed 2025-03-31 | 3.59M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | 1.87M shares 10-Q · filed 2024-05-09 | 1.88M shares derived: sum of 2 quarters · filed 2025-03-31 | 3.00M shares derived: sum of 3 quarters · filed 2025-03-31 | 3.14M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.13M shares derived: sum of 2 quarters · filed 2025-03-31 | 1.27M shares derived: sum of 3 quarters · filed 2025-03-31 | 2.59M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 1.11M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 1.25M shares derived: sum of 2 quarters · filed 2023-11-03 | 2.58M shares 10-Q · filed 2023-11-03 | 2.58M shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | 140.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 1.46M shares 10-Q · filed 2023-08-08 | 1.46M shares derived: sum of 3 quarters · filed 2024-03-28 | 1.47M shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | 1.32M shares 10-Q · filed 2023-05-09 | 1.32M shares derived: sum of 2 quarters · filed 2024-03-28 | 1.33M shares derived: sum of 3 quarters · filed 2024-03-28 | 1.33M shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 12.50K shares derived: sum of 2 quarters · filed 2024-03-28 | 12.50K shares derived: sum of 3 quarters · filed 2024-03-28 | 828.50K shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 12.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 12.50K shares derived: sum of 2 quarters · filed 2022-11-14 | 828.50K shares 10-Q · filed 2022-11-14 | 1.05M shares derived: sum of 4 quarters · filed 2023-03-21 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 816.00K shares 10-Q · filed 2022-08-04 | 1.04M shares derived: sum of 3 quarters · filed 2023-03-21 | 1.08M shares derived: sum of 4 quarters · filed 2023-03-21 |
| 2022-03-31 | 816.00K shares 10-Q · filed 2022-05-10 | 1.04M shares derived: sum of 2 quarters · filed 2023-03-21 | 1.08M shares derived: sum of 3 quarters · filed 2023-03-21 | 1.20M shares derived: sum of 4 quarters · filed 2023-03-21 |
| 2021-12-31 | 225.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | 260.00K shares derived: sum of 2 quarters · filed 2023-03-21 | 382.50K shares derived: sum of 3 quarters · filed 2023-03-21 | 1.25M shares 10-K · filed 2023-03-21 |
| 2021-09-30 | 35.00K shares 10-Q · filed 2022-11-14 | 157.50K shares derived: sum of 2 quarters · filed 2022-11-14 | 1.03M shares 10-Q · filed 2022-11-14 | 1.04M shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | 122.50K shares 10-Q · filed 2022-08-04 | 991.00K shares 10-Q · filed 2022-08-04 | 1.01M shares derived: sum of 3 quarters · filed 2022-08-04 | 1.24M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 868.50K shares 10-Q · filed 2021-05-10 | 886.00K shares derived: sum of 2 quarters · filed 2022-03-16 | 1.12M shares derived: sum of 3 quarters · filed 2022-03-16 | 1.12M shares derived: sum of 4 quarters · filed 2022-03-16 |
| 2020-12-31 | 17.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | 252.50K shares derived: sum of 2 quarters · filed 2022-03-16 | 253.70K shares derived: sum of 3 quarters · filed 2022-03-16 | 981.80K shares 10-K · filed 2022-03-16 |
| 2020-09-30 | 235.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 236.20K shares derived: sum of 2 quarters · filed 2020-11-09 | 964.30K shares 10-Q · filed 2020-11-09 | 1.43M shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2020-06-30 | 1.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 729.30K shares 10-Q · filed 2020-08-07 | 1.19M shares derived: sum of 3 quarters · filed 2021-03-09 | 1.21M shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2020-03-31 | 728.10K shares 10-Q · filed 2020-05-07 | 1.19M shares derived: sum of 2 quarters · filed 2021-03-09 | 1.21M shares derived: sum of 3 quarters · filed 2021-03-09 | 1.24M shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-12-31 | 462.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 478.50K shares derived: sum of 2 quarters · filed 2021-03-09 | 513.50K shares derived: sum of 3 quarters · filed 2021-03-09 | 1.29M shares 10-K · filed 2021-03-09 |
| 2019-09-30 | 16.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 51.00K shares derived: sum of 2 quarters · filed 2019-11-07 | 825.60K shares 10-Q · filed 2019-11-07 | 955.60K shares derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 809.60K shares 10-Q · filed 2019-08-08 | 939.60K shares derived: sum of 3 quarters · filed 2020-03-12 | 1.98M shares derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | 774.60K shares 10-Q · filed 2019-05-08 | 904.60K shares derived: sum of 2 quarters · filed 2020-03-12 | 1.95M shares derived: sum of 3 quarters · filed 2020-03-12 | 2.59M shares derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | 130.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 1.18M shares derived: sum of 2 quarters · filed 2020-03-12 | 1.81M shares derived: sum of 3 quarters · filed 2020-03-12 | 1.84M shares 10-K · filed 2020-03-12 |
| 2018-09-30 | 1.04M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 1.68M shares derived: sum of 2 quarters · filed 2018-11-13 | 1.71M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 635.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | 660.60K shares 10-Q · filed 2018-08-13 | ||
| 2018-03-31 | 25.00K shares 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | 1.09M shares 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |